Amit Sharma
Immunology and Microbiology · The Ohio State University
Publications
51
Citations
1,640
Est. group size
~2
Recurring co-author estimate
Active years
18
Publishing since 2009
Amit Sharma's research spans virology and cancer immunology, including how viruses like HIV and Zika interact with host immune defenses, as well as work on cancer biomarkers, gene therapy, and immune-based treatments for cancers such as glioblastoma and leukemia. The work combines laboratory experiments with computational and bioinformatics approaches to study disease mechanisms and identify potential therapeutic targets.
Publication output increased notably around 2020-2022 and has continued at a moderate, somewhat variable pace through 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Cell and gene therapy in Germany: three decades of advanced technologies
Immunotherapy · 2025
- Comprehensive bioinformatics and immunohistochemical analyses identify phosphoinositide metabolism and PNPLA7 as potential biomarkers in urological cancers
Scientific Reports · 2025
- Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma
Scientific Reports · 2025
- FOXN3-AS1: A Candidate Prognostic Marker and Epigenetic Target with Immunotherapeutic Implications in Acute Myeloid Leukemia
Current Medicinal Chemistry · 2024
- Exploring the promise of regulator of G Protein Signaling 20: insights into potential mechanisms and prospects across solid cancers and hematological malignancies
Cancer Cell International · 2024
- Network pharmacology and molecular modelling study of <i>Enhydra fluctuans</i> for the prediction of the molecular mechanisms involved in the amelioration of nephrolithiasis
Journal of Biomolecular Structure and Dynamics · 2023
- Inhibitory activity of Enhydra fluctuans Lour. on calcium oxalate crystallisation through in silico and in vitro studies
Frontiers in Pharmacology · 2023
- Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia
Figshare · 2022
- The Robust Restriction of Zika Virus by Type-I Interferon in A549 Cells Varies by Viral Lineage and Is Not Determined by IFITM3
Viruses · 2020
- Lineage-dependent differences and the role of IFITM3 in the type-I interferon-induced restriction of Zika virus
bioRxiv (Cold Spring Harbor Laboratory) · 2018
- CD4–HIV-1 Envelope Interactions: Critical Insights for the Simian/HIV/Macaque Model
AIDS Research and Human Retroviruses · 2018
- Owl monkey CCR5 reveals synergism between CD4 and CCR5 in HIV-1 entry
Virology · 2017
- Adapting SHIVs In Vivo Selects for Envelope-Mediated Interferon-α Resistance
PLoS Pathogens · 2016
- bioRxiv (Cold Spring Harbor Laboratory)×5
- PLoS Pathogens×3
- Journal of Virology×2
- Scientific Reports×2
- Bioconjugate Chemistry×1
- Netty Santoso
Immunology and Microbiology · The Ohio State University
- Kristine E. Yoder
Immunology and Microbiology · The Ohio State University
- Ross C. Larue
Immunology and Microbiology · The Ohio State University
- Rajni Kant Shukla
Immunology and Microbiology · The Ohio State University
- Ekaterina Knyazhanskaya
Immunology and Microbiology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile